Literature DB >> 14515137

DNA microarray profiling of developing PS1-deficient mouse brain reveals complex and coregulated expression changes.

Z K Mirnics1, K Mirnics, D Terrano, D A Lewis, S S Sisodia, N F Schor.   

Abstract

Presenilin 1 (PS1) plays a critical role in the nervous system development and PS1 mutations have been associated with familial Alzheimer's disease. PS1-deficient mice exhibit alterations in neural and vascular development and die in late embryogenesis. The present study was aimed at uncovering transcript networks that depend on intact PS1 function in the developing brain. To achieve this, we analyzed the brains of PS1-deficient and control animals at embryonic ages E12.5 and E14.5 using MG_U74Av2 oligonucleotide microarrays by Affymetrix. Based on the microarray data, overall molecular brain development appeared to be comparable between the E12.5 and E14.5 PS1-deficient and control embryos. However, in brains of PS1-deficient mice, we observed significant differences in the expression of genes encoding molecules that are associated with neural differentiation, extracellular matrix, vascular development, Notch-related signaling and lipid metabolism. Many of the expression differences between wild-type and PS1-deficient animals were present at both E12.5 and E14.5, whereas other transcript alterations were characteristic of only one developmental stage. The results suggest that the role of PS1 in development includes influences on a highly co-regulated transcript network; some of the genes participating in this expression network may contribute to the pathophysiology of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515137     DOI: 10.1038/sj.mp.4001389

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  8 in total

Review 1.  Blood-brain barrier genomics, proteomics, and new transporter discovery.

Authors:  Eric V Shusta
Journal:  NeuroRx       Date:  2005-01

Review 2.  Aging stem cells, latexin, and longevity.

Authors:  Ying Liang; Gary Van Zant
Journal:  Exp Cell Res       Date:  2008-02-19       Impact factor: 3.905

3.  Transcriptome of embryonic and neonatal mouse cortex by high-throughput RNA sequencing.

Authors:  Xinwei Han; Xia Wu; Wen-Yu Chung; Tao Li; Anton Nekrutenko; Naomi S Altman; Gong Chen; Hong Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-17       Impact factor: 11.205

4.  A Life at the Interface: The 2017 Hower Award Lecture.

Authors:  Nina F Schor
Journal:  Pediatr Neurol       Date:  2017-12-07       Impact factor: 3.372

5.  Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin.

Authors:  Irantzu Pallarès; Roman Bonet; Raquel García-Castellanos; Salvador Ventura; Francesc X Avilés; Josep Vendrell; F Xavier Gomis-Rüth
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

Review 6.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

7.  Chopper is prodeath regardless of the effect of p75ICD on sensitivity to oxidative stress.

Authors:  Alliya Qazi; Marc W Halterman; Zhiping Mi; Tong Zhang; Nina F Schor
Journal:  Oxid Med Cell Longev       Date:  2011-09-05       Impact factor: 6.543

8.  Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice.

Authors:  Károly Mirnics; Eric M Norstrom; Krassimira Garbett; Se Hoon Choi; Xiaoqiong Zhang; Philip Ebert; Sangram S Sisodia
Journal:  Mol Neurodegener       Date:  2008-10-03       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.